Cargando…
Reduced Sialylation and Bioactivity of the Antifibrotic Protein Serum Amyloid P in the Sera of Patients with Idiopathic Pulmonary Fibrosis
Pulmonary fibrosis is a chronic and generally fatal disorder characterized by progressive formation of scar-like tissue in the lungs. Sialic acids are often found as the terminal sugar on extracellular glycoconjugates such as protein glycosylations. Sialidases, also known as neuraminidases, desialyl...
Autores principales: | Chen, Wensheng, Karhadkar, Tejas R., Ryu, Changwan, Herzog, Erica L., Gomer, Richard H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500545/ https://www.ncbi.nlm.nih.gov/pubmed/32576593 http://dx.doi.org/10.4049/immunohorizons.2000043 |
Ejemplares similares
-
The sialidase NEU3 promotes pulmonary fibrosis in mice
por: Pilling, Darrell, et al.
Publicado: (2022) -
Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis
por: Karhadkar, Tejas R., et al.
Publicado: (2022) -
Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice
por: Karhadkar, Tejas R., et al.
Publicado: (2021) -
Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model
por: Karhadkar, Tejas R., et al.
Publicado: (2017) -
Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)